Amylyx Pharmaceuticals, Inc. Share Price: AMLX (Amylyx Pharmaceuticals, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Amylyx Pharmaceuticals, Inc. share price today?

Accepted Answer

Amylyx Pharmaceuticals, Inc. (AMLX) share price today is {{live_price}}.

Question 2

Can Indians buy Amylyx Pharmaceuticals, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Amylyx Pharmaceuticals, Inc. (AMLX) from India.

With INDmoney, you can buy Amylyx Pharmaceuticals, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Amylyx Pharmaceuticals, Inc. at zero transaction cost.

Question 3

How can I buy Amylyx Pharmaceuticals, Inc. shares from India?

Accepted Answer

It is very easy to buy Amylyx Pharmaceuticals, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Amylyx Pharmaceuticals, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Amylyx Pharmaceuticals, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Amylyx Pharmaceuticals, Inc. stocks?

Accepted Answer

To start investing in Amylyx Pharmaceuticals, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Amylyx Pharmaceuticals, Inc.

Accepted Answer

Today’s highest price of Amylyx Pharmaceuticals, Inc. (AMLX) is {{1_rba_end}}.

Today’s lowest price of Amylyx Pharmaceuticals, Inc. (AMLX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Amylyx Pharmaceuticals, Inc.

Accepted Answer

Today's market capitalisation of Amylyx Pharmaceuticals, Inc. AMLX is 853.4M

Question 8

What is the 52 Week High and Low Range of Amylyx Pharmaceuticals, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Amylyx Pharmaceuticals, Inc. is down from its 52 Week High?

Accepted Answer

Amylyx Pharmaceuticals, Inc. (AMLX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Amylyx Pharmaceuticals, Inc. is up from its 52 Week low?

Accepted Answer

Amylyx Pharmaceuticals, Inc. (AMLX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Amylyx Pharmaceuticals, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Amylyx Pharmaceuticals, Inc.

Accepted Answer

Mr. Joshua B. Cohen is the current Chief Executive Officer (CEO) of Amylyx Pharmaceuticals, Inc..

Period	Amylyx Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-31.1%	-1.3%	0.0%
6 Months	-43.53%	1.2%	0.0%
1 Year	-63.75%	-5.7%	-6.5%
3 Years	-21.31%	18.2%	-3.8%

Market Capitalization	853.4M
Book Value	$6.2
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	0.01
PE Ratio	1264.0
Wall Street Target Price	39.4

Profit Margin	0.62%
Operating Margin TTM	18.23%

Return On Assets TTM	-1.49%
Return On Equity TTM	0.65%

Revenue TTM	294.2M
Revenue Per Share TTM	4.41
Quarterly Revenue Growth YOY	29666.1%
Gross Profit TTM	-74.2M
EBITDA	-6.8M
Diluted Eps TTM	0.01
Quarterly Earnings Growth YOY	0.0

Amylyx Pharmaceuticals, Inc. (AMLX)

Increasing Revenue

Decreasing Net Profit

Vs SGEN

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	0.86
EPS Estimate Next Year	1.35
EPS Estimate Current Quarter	0.44
EPS Estimate Next Quarter	0.54

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amylyx Pharmaceuticals, Inc.	-21.09%	-43.53%	-63.75%	-21.31%	-21.31%
Moderna, Inc.	12.07%	-38.83%	-56.22%	-44.17%	329.19%
Regeneron Pharmaceuticals, Inc.	-0.48%	10.12%	6.32%	61.32%	112.97%
Novo Nordisk A/s	-0.53%	27.78%	58.23%	194.69%	336.14%
Seagen, Inc.	-0.96%	8.88%	73.78%	20.15%	232.63%
Vertex Pharmaceuticals Incorporated	-6.74%	5.21%	9.27%	54.9%	90.18%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amylyx Pharmaceuticals, Inc.	Buy	$853.4M	-21.31%	1264.0	0.62%
Moderna, Inc.	Buy	$29.6B	329.19%	24.73	-38.0%
Regeneron Pharmaceuticals, Inc.	Buy	$87.0B	112.97%	22.78	30.47%
Novo Nordisk A/s	Buy	$470.4B	336.14%	43.04	35.11%
Seagen, Inc.	Hold	$40.0B	232.63%	NA	-32.61%
Vertex Pharmaceuticals Incorporated	Buy	$91.0B	90.18%	26.52	35.94%

Organization	Amylyx Pharmaceuticals, Inc.
Employees	374
CEO	Mr. Joshua B. Cohen
Industry	Services